Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,470.00    50.00 (2.07%)
Bid:
2,466.00
Ask:
2,470.00
Spread: 4.00 (0.162%)
Market Cap: £7.93b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Acquisition

23 Nov 2017 07:00

RNS Number : 2712X
Bunzl PLC
23 November 2017
 

23 November 2017

 

 

BUNZL COMPLETES ACQUISTION IN FRANCE AND ANNOUNCES FURTHER EXPANSION IN AUSTRALIA AND BRAZIL

 

Bunzl plc, the international distribution and outsourcing Group, today announces that the acquisition of Hedis, Comptoir de Bretagne and Générale Collectivités, that was announced on 20 July 2017, has been completed following clearance of the transaction by the French Competition Authority.

 

The Company has also recently acquired Interpath in Australia and entered into an agreement to acquire Talge in Brazil.

 

Interpath, which is based in Melbourne, is principally engaged in the distribution of a variety of laboratory and healthcare related consumable products to the pathology, medical research and life science end user markets in Australia. Customers include public and private hospitals and other pathology and research laboratories. Revenue in the year ended June 2017 was A$22 million (c.£13 million).

 

Talge, which is based in Santa Catarina, is principally engaged in the sale of a variety of foodservice related products, mainly to redistributors in the southeast region of Brazil. Revenue in the year ended December 2016 was R$83 million (c.£20 million). Completion of the acquisition is subject to clearance of the transaction by the Brazilian competition authority.

 

Commenting on the acquisitions, Frank van Zanten, Chief Executive of Bunzl said:

 

"I am delighted that we have now completed the purchase of Hedis, Comptoir de Bretagne and Générale Collectivités. Together these businesses further expand our existing cleaning & hygiene operations in France and extend our business there into the catering equipment sector for the first time.

 

The acquisition of Interpath has enhanced our healthcare business in Australia and extended our product offering into the pathology, medical research and life science markets there, while the proposed purchase of Talge will expand our operations into the foodservice sector in Brazil."

 

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive

Brian May, Finance Director

Tel: 020 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: 020 7353 4200

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBTBATMBTTBTR
Date   Source Headline
3rd May 201610:50 amRNSBlock listing Interim Review
20th Apr 20162:40 pmRNSResult of AGM
20th Apr 20167:00 amRNSTrading Statement
14th Apr 20164:59 pmRNSDirector/PDMR Shareholding
11th Apr 20164:32 pmRNSDirector/PDMR Shareholding
6th Apr 201612:05 pmRNSDirector/PDMR Shareholding
6th Apr 201611:32 amRNSDirector/PDMR Shareholding
1st Apr 20161:48 pmRNSTotal Voting Rights
31st Mar 20164:39 pmRNSDirector/PDMR Shareholding
31st Mar 201612:05 pmRNSDirector Declaration
29th Mar 20162:49 pmRNSDirector/PDMR Shareholding
23rd Mar 20164:50 pmRNSDirector/PDMR Shareholding
23rd Mar 201612:11 pmRNSAdditional Listing
17th Mar 20163:05 pmRNSAnnual Financial Report
15th Mar 20164:32 pmRNSDirector/PDMR Shareholding
14th Mar 20164:49 pmRNSDirector/PDMR Shareholding
11th Mar 20164:59 pmRNSDirector/PDMR Shareholding
4th Mar 20162:55 pmRNSDirector/PDMR Shareholding
3rd Mar 20161:37 pmRNSDirector/PDMR Shareholding
2nd Mar 20164:51 pmRNSDirector/PDMR Shareholding
1st Mar 20164:58 pmRNSDirector/PDMR Shareholding
1st Mar 20164:57 pmRNSDirector/PDMR Shareholding
1st Mar 201612:39 pmRNSTotal Voting Rights
29th Feb 20161:09 pmRNSDividend Declaration
29th Feb 20167:00 amRNSFinal Results
29th Feb 20167:00 amRNSAcquisition
3rd Feb 20162:35 pmRNSDirector/PDMR Shareholding
1st Feb 201612:10 pmRNSTotal Voting Rights
18th Jan 201611:46 amRNSDirector Declaration
14th Jan 20167:00 amRNSDirectorate Change
13th Jan 20169:56 amRNSDirector/PDMR Shareholding
6th Jan 20164:03 pmRNSDirector/PDMR Shareholding
4th Jan 20161:51 pmRNSTotal Voting Rights
16th Dec 20157:00 amRNSTrading Statement
4th Dec 20159:50 amRNSDirector/PDMR Shareholding
1st Dec 20153:43 pmRNSTotal Voting Rights
30th Nov 20152:31 pmRNSHolding(s) in Company
9th Nov 20154:42 pmRNSDirector/PDMR Shareholding
6th Nov 20157:00 amRNSAcquisition
4th Nov 20154:28 pmRNSDirector/PDMR Shareholding
4th Nov 201512:42 pmRNSAdditional Listing
2nd Nov 201510:50 amRNSBlocklisting Interim Review
2nd Nov 201510:45 amRNSTotal Voting Rights
22nd Oct 20159:55 amRNSDirector/PDMR Shareholding
21st Oct 20157:00 amRNSTrading Statement
15th Oct 20159:13 amRNSHolding(s) in Company
9th Oct 20154:46 pmRNSDirector/PDMR Shareholding
8th Oct 20154:07 pmRNSDirector/PDMR Shareholding
7th Oct 20153:48 pmRNSDirector/PDMR Shareholding
6th Oct 20154:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.